{"name": "InterMed Discovery",
 "permalink": "intermed-discovery",
 "crunchbase_url": "http://www.crunchbase.com/company/intermed-discovery",
 "homepage_url": "http://www.intermed-discovery.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "cleantech",
 "number_of_employees": null,
 "founded_year": 2006,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@intermed-discovery.com",
 "phone_number": "49-(0)231-9742-6060",
 "description": "Natural Product lead-discovery",
 "created_at": "Sat Jun 13 12:04:54 UTC 2009",
 "updated_at": "Thu Jul 02 20:04:44 UTC 2009",
 "overview": "\u003Cp\u003EInterMed Discovery is an emerging world class Natural Product lead-discovery company, driving innovation through the generation of novel product candidates for the life science, food and cosmetics industries.\u003C/p\u003E\n\n\u003Cp\u003EUsing one of the most powerful validated Natural Product discovery engines, InterMed Discovery generates proprietary product pipelines of early stage pharmaceuticals and functional ingredients and also supports partners in research and lead generation. Biologically characterised product leads are identified using IMD Bioprofiling\u00c2\u00ae and NPsilico\u00c2\u00ae, which together comprise a proprietary bioinformatics platform drawing on screening results compiled over many years, complemented by primary biological and chemical research on Natural Products.\u003C/p\u003E\n\n\u003Cp\u003EInterMed Discovery adds to this the industry\u00e2\u20ac\u2122s largest collections of pure compounds, sample fractions and mixtures as its source for potential Natural Product LEADs. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       55],
      "assets/images/resized/0004/8364/48364v1-max-150x150.png"],
     [[226,
       84],
      "assets/images/resized/0004/8364/48364v1-max-250x250.png"],
     [[226,
       84],
      "assets/images/resized/0004/8364/48364v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Managing Director",
    "person":
     {"first_name": "Dr.",
      "last_name": "Thomas Henkel",
      "permalink": "dr-thomas-henkel",
      "image":
       {"available_sizes":
         [[[150,
            119],
           "assets/images/resized/0004/8367/48367v1-max-150x150.jpg"],
          [[180,
            143],
           "assets/images/resized/0004/8367/48367v1-max-250x250.jpg"],
          [[180,
            143],
           "assets/images/resized/0004/8367/48367v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Director Operations",
    "person":
     {"first_name": "Dr.",
      "last_name": "Matthias Gehling",
      "permalink": "dr-matthias-gehling",
      "image":
       {"available_sizes":
         [[[150,
            119],
           "assets/images/resized/0004/8369/48369v1-max-150x150.jpg"],
          [[180,
            143],
           "assets/images/resized/0004/8369/48369v1-max-250x250.jpg"],
          [[180,
            143],
           "assets/images/resized/0004/8369/48369v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Managing Director",
    "person":
     {"first_name": "Bernard",
      "last_name": "Mathias Becker",
      "permalink": "bernard-mathias-becker",
      "image":
       {"available_sizes":
         [[[150,
            119],
           "assets/images/resized/0004/8368/48368v1-max-150x150.jpg"],
          [[180,
            143],
           "assets/images/resized/0004/8368/48368v1-max-250x250.jpg"],
          [[180,
            143],
           "assets/images/resized/0004/8368/48368v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac7.44M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.intermed-discovery.com/language=en/5692/2009-01-13-intermed-discovery-closes-equity-transaction-worth-7-44-m-with-biotropics-malaysia-berhad.html",
    "source_description": "InterMed Discovery Closes Equity Transaction Worth \u00e2\u201a\u00ac7,44 M with Biotropics Malaysia Berhad",
    "raised_amount": 7440000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2009,
    "funded_month": 1,
    "funded_day": 13,
    "investments":
     [{"company":
        {"name": "Biotropics Malaysia Berhad",
         "permalink": "biotropics-malaysia-berhad",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0010/9195/109195v1-max-150x150.jpg"],
             [[190,
               66],
              "assets/images/resized/0010/9195/109195v1-max-250x250.jpg"],
             [[190,
               66],
              "assets/images/resized/0010/9195/109195v1-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Otto-Hahn-Str. 15",
    "address2": "44227 Dortmund",
    "zip_code": "",
    "city": "",
    "state_code": null,
    "country_code": "DEU",
    "latitude": 51.4983521,
    "longitude": 6.8126313}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        98],
       "assets/images/resized/0004/8365/48365v1-max-150x150.jpg"],
      [[250,
        163],
       "assets/images/resized/0004/8365/48365v1-max-250x250.jpg"],
      [[450,
        294],
       "assets/images/resized/0004/8365/48365v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}